An instructive case of amlodipine-induced reversible granulomatous CD30+ T-cell pseudolymphoma

被引:3
|
作者
Cheong, Kah Wai [1 ]
Lim, Gareth Zigui [1 ]
Tan, Kong Bing [2 ,3 ]
Lim, Joel Hua-Liang [4 ]
机构
[1] Natl Univ Hlth Syst, Tan Tock Seng Hosp, Singapore, Singapore
[2] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore
[3] Natl Univ Singapore, Singapore, Singapore
[4] Natl Skin Ctr, Singapore, Singapore
关键词
amlodipine; CD30+lymphoproliferative disorder; cutaneous T cell lymphoma; drug-associated reversible granulomatous T-cell dyscrasia; drug-induced pseudolymphoma; eosinophilia; interstitial granulomatous drug reaction; mycosis fungoides;
D O I
10.1111/ajd.13240
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report an unusual case of drug-associated granulomatous CD30(+) T-cell pseudolymphoma secondary to amlodipine. A 55-year-old Chinese man presented with a 6-month eruption of disseminated erythematous dermal papulonodules and annular infiltrated plaques over his neck and limbs symmetrically. Histopathology revealed a perivascular and interstitial infiltrate of histiocytes, eosinophils and morphologically normal lymphocytes associated with CD30 expression. The eruption improved rapidly after discontinuation of amlodipine and did not recur.
引用
收藏
页码:E346 / E350
页数:5
相关论文
共 50 条
  • [21] CD30-positive cutaneous T-cell lymphoma with concurrent solid tumour
    Au, WY
    Yeung, CK
    Chan, HH
    Wong, RWM
    Shek, TW
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (06) : 1091 - 1095
  • [22] Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients
    Wechsler, Janine
    Ingen-Housz-Oro, Saskia
    Deschamps, Lydia
    Brunet-Possenti, Florence
    Deschamps, Justin
    Delfau, Marie-Helene
    Calderaro, Julien
    Ortonne, Nicolas
    PATHOLOGY, 2022, 54 (06) : 729 - 737
  • [23] Autopsy case of CD4-/CD8- cutaneous T-cell lymphoma presenting disseminated pagetoid reticulosis with aggressive granulomatous invasion to the lungs and pancreas
    Shiozawa, E
    Shiokawa, A
    Shibata, M
    Nakada, T
    Yamochi-Onizuka, T
    Saito, B
    Takaba, E
    Iijima, M
    Takimoto, M
    Ota, H
    PATHOLOGY INTERNATIONAL, 2005, 55 (01) : 32 - 39
  • [24] Granulomatous Slack Skin T-Cell Lymphoma Manifesting as Ulcerative and Gangrenous Lesions With a Fatal Outcome: A Case Report and Review of the Literature
    Su, Ruijun Jeanna
    Said, Jonathan
    Kallen, Michael E.
    Jumniensuk, Chayanit
    Pullarkat, Sheeja
    AJSP-REVIEWS AND REPORTS, 2019, 24 (06): : 267 - 271
  • [25] Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15+CD30- phenotype
    Yoshizawa, Naho
    Yagi, Hiroaki
    Horibe, Takahiro
    Takigawa, Masahiro
    Sugiura, Makoto
    EUROPEAN JOURNAL OF DERMATOLOGY, 2007, 17 (05) : 441 - 442
  • [26] A case of primary cutaneous CD30 positive anaplastic large cell lymphoma in a patient with granulomatous mycosis fungoides
    Seol, J. E.
    Cho, G. J.
    Kim, J. U.
    Park, S. H.
    Jin, W. J.
    Kim, H.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2020, 28 (03): : 115 - 120
  • [27] Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report
    Salva, Katrin A.
    Bennett, Daniel
    Longley, Jack
    Guitart, Joan
    Wood, Gary S.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2015, 37 (10) : E116 - E121
  • [28] Neurotropic Gamma-Delta T-Cell Lymphoma With CD30-Positive Lymphoid Infiltrates
    Gammon, Bryan
    Gammon, Benjamin R.
    Kim, Youn H.
    Kim, Jinah
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2016, 38 (09) : E133 - E136
  • [29] The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas
    Karube, Kennosuke
    Kakimoto, Yoshihide
    Tonozuka, Yukio
    Ohshima, Koichi
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (08) : 777 - 787
  • [30] Antibody-Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism
    Jiang, Yi
    Dong, Sai
    Wang, Yang
    CANCERS, 2025, 17 (03)